Alpha Tau Medical (DRTS) Other Non Operating Income (2021 - 2024)
Alpha Tau Medical (DRTS) posted Other Non Operating Income of $8.1 million for Q4 2024, up 230.2% sequentially from -$6.3 million in Q3 2024, and down 24.74% YoY from $10.8 million in Q1 2024.
Powered by 
Analysis
Alpha Tau Medical (DRTS) Other Non Operating Income (2021 - 2024) Analysis & Trends
Alpha Tau Medical has reported Other Non Operating Income for 2 years, with the latest figure at $8.1 million in Q4 2024.
- Quarterly Other Non Operating Income fell 24.74% year-over-year to $8.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $6.6 million (changed N/A YoY) and the FY2025 annual result came in at $3.8 million, down 17.34% from the prior year.
- Other Non Operating Income advanced to $8.1 million in Q4 2024 per DRTS's latest filing, from -$6.3 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $10.8 million in Q4 2023 and troughed at -$6.3 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.21 Bn | 1.11 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 8.14 Mn |
| Sep 30, 2024 | -6.25 Mn |
| Dec 31, 2023 | 10.82 Mn |
| Sep 30, 2023 | -6.11 Mn |
| Jun 30, 2022 | -6.02 Mn |
| Mar 31, 2022 | 16.96 Mn |
| Mar 31, 2021 | 8.97 Mn |